In the ‘eternal arms race’ between pathogen and host, cells employ the same gene to fight both SARS-CoV-2 and HIV, revealing new avenues for potential therapies.
Patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the steroid dexamethasone.
New research on an enigmatic neurotransmitter receptor in the brain reveals it may be a promising target for future novel therapeutic treatments for a host of neurological diseases, according to Gabriela K. Popescu, PhD, professor of biochemistry.
Sherice Simpson is the eighth Jacobs School of Medicine and Biomedical Sciences medical student to participate in the National Institute of Health’s (NIH) Medical Research Scholars Program (MRSP).
